Clinical Trial Update: PM8002 (BNT327) in Combination With Chemotherapy in Patients With Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial update for PM8002 (BNT327) in combination with chemotherapy for metastatic colorectal cancer, currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• PM8002 (BNT327) (BNT327)

Snippet

Sponsor: Biotheus Inc. | Conditions: CRC (Colorectal Cancer) | Phase 2 | Status: NOT_YET_RECRUITING